Prot# CPG 10101-004: CPG 10101 Combination Therapy for the Treatment of Hepatitis C: A Phase II Randomized, Open-Label, Multi-Center, Parallel Arm, Controlled Trial of CPG 10101 at 2 Different Dose Levels w/Pegylated-Interferon-Alpha 2B (PEG-IFN) Plus Rib

Project: Research project

Project Details

StatusFinished
Effective start/end date5/8/068/10/10

Funding

  • Coley Pharmaceutical Group, Inc. (CPG 10101-004)